Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.05 USD | -3.67% | -8.70% | +21.39% |
May. 08 | Earnings Flash (KPTI) KARYOPHARM THERAPEUTICS Reports Q1 Revenue $33.1M, vs. Street Est of $34.5M | MT |
May. 08 | Transcript : Karyopharm Therapeutics Inc., Q1 2024 Earnings Call, May 08, 2024 |
Business Summary
Number of employees: 325
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Drugs
100.0
%
| 157 | 100.0 % | 146 | 100.0 % | -7.03% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 157 | 100.0 % | 146 | 100.0 % | -7.03% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Richard Paulson
CEO | Chief Executive Officer | 56 | 20-02-25 |
Mike Mason
DFI | Director of Finance/CFO | 49 | 19-02-24 |
Amama Sadiq
CTO | Chief Tech/Sci/R&D Officer | - | 23-03-31 |
Accumanno James
CMP | Compliance Officer | - | 21-04-30 |
Reshma Rangwala
CTO | Chief Tech/Sci/R&D Officer | 46 | 22-03-31 |
Elhan Webb
IRC | Investor Relations Contact | - | 22-03-13 |
Lisa DiPaolo
HRO | Human Resources Officer | - | 22-08-31 |
Stuart Poulton
PRN | Corporate Officer/Principal | 51 | 22-01-31 |
Sohanya Cheng
PRN | Corporate Officer/Principal | 41 | 21-06-07 |
Michael Mano
LAW | General Counsel | 47 | 20-12-14 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Garen Bohlin
BRD | Director/Board Member | 76 | 13-10-02 |
Barry Greene
BRD | Director/Board Member | 60 | 12-12-31 |
Director/Board Member | 59 | 13-03-31 | |
Chen Schor
BRD | Director/Board Member | 51 | 20-11-24 |
Mansoor Mirza
BRD | Director/Board Member | 63 | 10-09-30 |
Richard Paulson
CEO | Chief Executive Officer | 56 | 20-02-25 |
Christy Oliger
BRD | Director/Board Member | 54 | 20-08-27 |
Su Zhen
BRD | Director/Board Member | 47 | 23-08-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 117,710,263 | 112,573,414 ( 95.64 %) | 0 | 95.64 % |
Company contact information
Karyopharm Therapeutics, Inc.
85 Wells Avenue Suite 210, 2nd floor
02459-3298, Newton
+617 658 0600
http://www.karyopharm.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.39% | 124M | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.69% | 21.78B | |
-10.60% | 18.09B | |
-41.25% | 16.72B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- KPTI Stock
- Company Karyopharm Therapeutics Inc.